李涛,程振业,李学香,霍凤洁,王海鹰,程应樟,卢旭

• 1:莱州市人民医院心血管内科
• 2:南昌大学第二附属医院心血管内科

摘要(Abstract)：

本文报道1例原发性血小板增多症合并双支血管急性闭塞的急性ST段抬高型心肌梗死患者救治体会。患者为左前降支、右冠状动脉同时闭塞的急性ST段抬高型心肌梗死，经急诊介入治疗行冠状动脉球囊扩张术、血栓抽吸术，冠状动脉内给予替罗非班、尿激酶原溶栓治疗，恢复心肌梗死溶栓治疗试验血流分级Ⅲ级。术后完善相关检查，明确诊断为原发性血小板增多症。更改治疗方案，加用羟基脲，继续给予双联抗血小板聚集、低分子肝素抗凝治疗。患者康复出院，随访3个月，患者血小板计数明显降低，未再出现胸痛症状，无血栓及出血事件发生。

关键词(KeyWords)： 原发性血小板增多症;双支血管急性闭塞;急性ST段抬高型心肌梗死

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李涛,程振业,李学香,霍凤洁,王海鹰,程应樟,卢旭

参考文献(References)：

• [1] Campbell PJ,MacLean C,Beer PA,et al. Correlation of blood counts with vascular complications in essential thrombocythemia:analysis of the prospective PT1 cohort[J].Blood,2012,120(7):1409-1411.
• [2] Barbui T,Finazzi G,Carobbio A,et al.Development and validation of an international prognostic score of thrombosis in World Health Organization-essential thrombocythemia(IPSET-thrombosis)[J]. Blood,2012,120(26):5128-5133.
• [3] Rumi E,Cazzola M. How I treat essential thrombocythemia[J].Blood,2016,128(20):2403-2414.
• [4] Barbui T,Falanga A. Molecular biomarkers of thrombosis in myeloproliferative neoplasms[J]. Thromb Res,2016,140 Suppl1:S71-S75.
• [5] Rossi C,Randi ML,Zerbinati P,et al. Acute coronary disease in essential thrombocythemia and polycythemia vera[J]. J Intern Med,1998,244(1):49-53.
• [6]肖志坚.原发性血小板增多症诊断与治疗中国专家共识（2016年版）[J].中华血液学杂志，2016,37(10):833-836.
• [7]张金，郭荣，李晓红，等.原发性血小板增多症合并冠状动脉粥样硬化性心脏病患者的临床特征分析[J].中国现代医学杂志，2020,30(9):75-79.
• [8] Tortorella G,Calzolari M,Tieghi A,et al. Acute coronary syndrome(ACS)in patients with essential thrombocytemia(ET). What is the best treatment[J]? Int J Cradiol,2016,203:225-227.
• [9] Shoji K,Yanishi K,Shiraishi J,et al. In-stent massive thrombi formation during primary percutaneous coronary intervention in a patient with acute myocardial infarction complicated with essential thrombocythemia[J]. Intern Med,2019,58(9):1287-1293.
• [10]韩业晨，谢洪智，张抒扬.原发性血小板增多症患者经皮冠状动脉介入治疗随访结果分析[J].中国介入心脏病学杂志，2018,26(4):209-212.
• [11] Kumagai N,Mitsutake R,Miura S,et al. Acute coronary syndrome associated with essential thrombocythemia[J]. J Cardiol,2009,54(3):485-489.
• [12] Valgimigli M,Bueno H,Byrne RA,et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for CardioThoracic Surgery(EACTS)[J]. Eur Heart J,2018,39(3):213-260.